Latest News and Press Releases
Want to stay updated on the latest news?
-
QUÉBEC, 31 juill. 2024 (GLOBE NEWSWIRE) -- UgoWork™, un fournisseur de premier plan de solutions avancées de stockage d'énergie pour les véhicules de manutention, a annoncé aujourd'hui la...
-
QUEBEC, July 31, 2024 (GLOBE NEWSWIRE) -- UgoWork™, a premier provider of advanced energy storage solutions for material handling equipment, today announced the closing of $51M as part of its Series...
-
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...
-
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...
-
PARIS, June 02, 2022 (GLOBE NEWSWIRE) -- Diabeloop secures 70 million euros to pursue its solid and sustained growth strategy. The automated insulin delivery pioneer, develops machine-learning...
-
eureKARE participates in DNA Script’s $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France –...
-
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
-
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...
-
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
-
BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced the closing of a $26.3 million Series C...